A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance

Clinical trial NCT04018365 · UNKNOWN

Trial details

NCT number: NCT04018365
Sponsor: Kobe University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Insulin Resistance - Type A Insulin Resistance - Type B Lipoatrophic Diabetes Mellitus Insulin Resistance Syndrome

Start date: 2019-09-01
Primary completion: 2021-07-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.